{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:04Z","timestamp":1793051884323,"version":"4.5.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Huntington\u2019s disease (HD), a neurodegenerative disease, normally starts in the prime of adult life, followed by a gradual occurrence of psychiatric disturbances, cognitive and motor dysfunction. The daily performances and life quality of HD patients have been severely interfered by these clinical signs and symptoms until the last stage of neuronal cell death. To the best of our knowledge, no treatment is available to completely mitigate the progression of HD. Mangiferin, a naturally occurring potent glucoxilxanthone, is mainly isolated from the <jats:italic>Mangifera indica<\/jats:italic> plant. Considerable studies have confirmed the medicinal benefits of mangiferin against memory and cognitive impairment in neurodegenerative experimental models such as Alzheimer\u2019s and Parkinson\u2019s diseases. Therefore, this study aims to evaluate the neuroprotective effect of mangiferin against 3-nitropropionic acid (3-NP) induced HD in rat models. Adult Wistar rats (<jats:italic>n<\/jats:italic> = 32) were randomly allocated equally into four groups of eight rats each: normal control (Group I), disease control (Group II) and two treatment groups (Group III and Group IV). Treatment with mangiferin (10 and 20\u00a0mg\/kg, p. o.) was given for 14\u00a0days, whereas 3-NP (15\u00a0mg\/kg, i. p.) was given for 7\u00a0days to induce HD-like symptoms in rats. Rats were assessed for cognitive functions and motor coordination using open field test (OFT), novel object recognition (NOR) test, neurological assessment, rotarod and grip strength tests. Biochemical parameters such as oxidative stress markers and pro-inflammatory markers in brain hippocampus, striatum and cortex regions were evaluated. Histopathological study on brain tissue was also conducted using hematoxylin and eosin (H&amp;amp;E) staining. 3-NP triggered anxiety, decreased recognition memory, reduced locomotor activity, lower neurological scoring, declined rotarod performance and grip strength were alleviated by mangiferin treatment. Further, a significant depletion in brain malondialdehyde (MDA) level, an increase in reduced glutathione (GSH) level, succinate dehydrogenase (SDH), superoxide dismutase (SOD) and catalase (CAT) activities, and a decrease in tumor necrosis factor-alpha (TNF-\u03b1), interleukin-1 beta (IL-1\u03b2) and interleukin-6 (IL-6) levels were observed in mangiferin treated groups. Mangiferin also mitigated 3-NP induced histopathological alteration in the brain hippocampus, striatum and cortex sections. It could be inferred that mangiferin protects the brain against oxidative damage and neuroinflammation, notably via antioxidant and anti-inflammatory activities. Mangiferin, which has a good safety profile, may be an alternate treatment option for treating HD and other neurodegenerative disorders. The results of the current research of mangiferin will open up new avenues for the development of safe and effective therapeutic agents in diminishing HD.<\/jats:p>","DOI":"10.3389\/fphar.2023.1189957","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T10:27:27Z","timestamp":1689244047000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms"],"prefix":"10.3389","volume":"14","author":[{"given":"Pei Teng","family":"Lum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendran","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay Jing","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Farooq","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Arulsamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaarvena","family":"Retinasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Hua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Gnanaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norhaizan Mohd","family":"Esa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gobinath","family":"Ramachawolran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vetriselvan","family":"Subramaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh V.","family":"Chinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan Seng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.ijbiomac.2021.06.022","article-title":"A review on the role of TANK-binding kinase 1 signaling in cancer","volume":"183","author":"Alam","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2007.03.025","article-title":"Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells","volume":"418","author":"Amazzal","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in huntington's disease: A balancing act","volume":"16","author":"Andre","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: Neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"key":"B5","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/14737175.2019.1631161","article-title":"Emerging therapies in Huntington\u2019s disease","volume":"19","author":"Bashir","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13596-016-0237-7","article-title":"Protective effect of Ficus religiosa (L) against 3-nitropropionic acid induced Huntington disease","volume":"16","author":"Bhangale","year":"2016","journal-title":"Orient. Pharm. Exp. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.abb.2008.06.017","article-title":"Mangiferin inhibits cyclooxygenase-2 expression and prostaglandin E2 production in activated rat microglial cells","volume":"477","author":"Bhatia","year":"2008","journal-title":"Archives Biochem. Biophysics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1089\/jmf.2012.2698","article-title":"Neuroprotective effect of lutein against 3-nitropropionic acid\u2013induced huntington's disease\u2013like symptoms: Possible behavioral, biochemical, and cellular alterations","volume":"16","author":"Binawade","year":"2013","journal-title":"J. Med. Food"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjo\u0308rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9.48.1","DOI":"10.1002\/0471142301.ns0948s67","article-title":"The 3-NP model of striatal neurodegeneration","volume":"67","author":"Brouillet","year":"2014","journal-title":"Curr. Protoc. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cns.12189","article-title":"Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's disease","volume":"20","author":"Chakraborty","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.biopha.2018.06.079","article-title":"Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats","volume":"105","author":"Danduga","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.3390\/ijms22115995","article-title":"Nrf2 activation attenuates acrylamide-induced neuropathy in mice","volume":"22","author":"Davuljigari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/TCRM.S17152","article-title":"Management of huntington\u2019s disease: role of tetrabenazine","volume":"7","author":"de Tommaso","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","article-title":"Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats","volume":"77","author":"Dhadde","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41467-017-02752-1","article-title":"CA1 and CA3 differentially support spontaneous retrieval of episodic contexts within human hippocampal subfields","volume":"9","author":"Dimsdale-Zucker","year":"2018","journal-title":"Nat. Commun."},{"key":"B18","first-page":"115","article-title":"A rapid neurobehavioral assessment reveals that FK506 delays symptom onset in R6\/2 Huntington's disease mice","volume":"1","author":"Ditzler","year":"2003","journal-title":"Preclin. Res. Articles"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington\u2019s disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"J. Immunol. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1248\/bpb.b14-00128","article-title":"Protective effect of chinonin in MPTP-induced C57BL\/6 mouse model of Parkinson\u2019s disease","volume":"37","author":"Feng","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"B21","doi-asserted-by":"publisher","first-page":"104336","DOI":"10.1016\/j.phrs.2019.104336","article-title":"Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s disease models","volume":"146","author":"Feng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B22","first-page":"769","article-title":"Beneficial effect of Mangiferin against sleep deprivation-induced neurodegeneration and memory impairment in mice","volume":"28","author":"Feng","year":"2017","journal-title":"Biomed. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1089\/neu.2016.4708","article-title":"A mouse model of bilateral cervical contusion-compression spinal cord injury","volume":"34","author":"Forgione","year":"2017","journal-title":"J. Neurotrauma"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S585","DOI":"10.1192\/j.eurpsy.2021.1560","article-title":"Suicidal behaviour in huntington disease","volume":"64","author":"Freitas","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10571-014-0039-8","article-title":"Mangiferin regulates interleukin-6 and cystathionine-b-synthase in lipopolysaccharide-induced brain injury","volume":"34","author":"Fu","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/aps.2014.107","article-title":"Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease","volume":"36","author":"Gao","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"B27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/B978-0-12-374279-7.10001-3","article-title":"The interleukin-1 family","volume-title":"Encyclopedia of immunobiology","author":"Garlanda","year":"2016"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cortex.2019.07.014","article-title":"Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory","volume":"119","author":"Harris","year":"2019","journal-title":"Cortex"},{"key":"B30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1176\/jnp.15.1.109","article-title":"On chorea. George Huntington, M.D","volume":"15","author":"Huntington","year":"2003","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajme.2017.09.001","article-title":"First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid","volume":"54","author":"Ighodaro","year":"2018","journal-title":"Alexandria J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1007\/s12035-016-0015-z","article-title":"Long-term mangiferin extract treatment improves central pathology and cognitive deficits in APP\/PS1 mice","volume":"54","author":"Infante-Garcia","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/gt.2014.101","article-title":"Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis","volume":"22","author":"Jackson","year":"2015","journal-title":"Gene Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.physbeh.2015.12.015","article-title":"Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: Possible role of oxidative stress, neuroinflammation, and neurotransmitters","volume":"155","author":"Jamwal","year":"2016","journal-title":"Physiology Behav."},{"key":"B35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbi.2019.03.001","article-title":"Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington\u2019s disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors","volume":"80","author":"Jang","year":"2019","journal-title":"Brain, Behav. Immun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejphar.2014.07.031","article-title":"Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice","volume":"740","author":"Jangra","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"117476","DOI":"10.1016\/j.lfs.2020.117476","article-title":"Mangiferin exert cardioprotective and anti-apoptotic effects in heart failure induced rats","volume":"249","author":"Jiang","year":"2020","journal-title":"Life Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/biof.1308","article-title":"Mangiferin: A review of sources and interventions for biological activities","volume":"42","author":"Jyotshna","year":"2016","journal-title":"BioFactors"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"722","DOI":"10.25258\/phyto.v9i5.8155","article-title":"Protective activity of esculetin against 3-nitropropionic acid induced neurotoxicity via scavenging reactive oxygen species in male wistar rats","volume":"9","author":"Karandikar","year":"2017","journal-title":"Int. J. Pharmacogn. Phytochemical Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtemb.2015.04.002","article-title":"Mangiferin ameliorates aluminium chloride-induced cognitive dysfunction via alleviation of hippocampal oxido-nitrosative stress, proinflammatory cytokines and acetylcholinesterase level","volume":"31","author":"Kasbe","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0960327110361752","article-title":"Antigenotoxic effect of mangiferin and changes in antioxidant enzyme levels of Swiss albino mice treated with cadmium chloride","volume":"29","author":"Kasi","year":"2010","journal-title":"Hum. Exp. Toxicol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1179\/1476830515Y.0000000022","article-title":"Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats","volume":"19","author":"Kaur","year":"2016","journal-title":"Nutr. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cbi.2013.09.016","article-title":"Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2\/Bax expression in experimental Parkinson\u2019s disease mice","volume":"206","author":"Kavitha","year":"2013","journal-title":"Chemico-Biological Interact."},{"key":"B45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-801893-4.00003-1","article-title":"Epidemiology of huntington disease","volume":"144","author":"Kay","year":"2017","journal-title":"Handb. Clin. Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/brainsci10010043","article-title":"Therapeutic advances for Huntington\u2019s disease","volume":"10","author":"Kumar","year":"2020","journal-title":"Brain Sci."},{"key":"B47","first-page":"297","article-title":"Huntington disease: Report of first case documented in Malaysia","volume":"49","author":"Lee","year":"1994","journal-title":"Med. J. Malays."},{"key":"B48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/B978-0-12-803750-8.00049-X","article-title":"Chapter 49 - cocaine and cerebral sigma-1 receptor occupancy","volume-title":"The neuroscience of cocaine","author":"Lever","year":"2017"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.cellsig.2011.05.016","article-title":"Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells","volume":"23","author":"Li","year":"2011","journal-title":"Cell. Signal."},{"key":"B50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ddr.21783","article-title":"Neuroprotective mechanisms of mangiferin in neurodegenerative diseases","volume":"82","author":"Liu","year":"2021","journal-title":"Drug Dev. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e55718","DOI":"10.3791\/55718","article-title":"Novel object recognition test for the investigation of learning and memory in mice","volume":"126","author":"Lueptow","year":"2017","journal-title":"J. Vis. Exp."},{"key":"B52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.sjbs.2020.11.037","article-title":"Protective effect of mangiferin on memory impairment: A systematic review","volume":"28","author":"Lum","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/01616412.2017.1310705","article-title":"Mangiferin prevents corticosterone-induced behavioural deficits via alleviation of oxido-nitrosative stress and down-regulation of indoleamine 2, 3-dioxygenase (Ido) activity","volume":"39","author":"Luo","year":"2017","journal-title":"Neurological Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/jpm12060864","article-title":"Sleep quality and related clinical manifestations in Huntington disease","volume":"12","author":"Maffi","year":"2022","journal-title":"J. Personalized Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11064-013-1225-7","article-title":"Puerarin ameliorates 3-nitropropionic acid-induced neurotoxicity in rats: Possible neuromodulation and antioxidant mechanisms","volume":"39","author":"Mahdy","year":"2014","journal-title":"Neurochem. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1080\/13880209.2017.1285945","article-title":"Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: Possible antioxidant mechanism","volume":"55","author":"Malik","year":"2017","journal-title":"Pharm. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/1028415X.2020.1841500","article-title":"Neuroprotective effect of standardized extracts of three Lactuca sativa Linn. varieties against 3-NP induced Huntington\u2019s disease like symptoms in rats","volume":"25","author":"Malik","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2174\/138955713804999838","article-title":"Mangiferin\u2013a bioactive xanthonoid, not only from mango and not just antioxidant","volume":"13","author":"Matkowski","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/ijp.IJP_11_18","article-title":"Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction","volume":"50","author":"Mehan","year":"2018","journal-title":"Indian J. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4103\/1673-5374.200812","article-title":"Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders","volume":"12","author":"Mehan","year":"2017","journal-title":"Neural Regen. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"147444","DOI":"10.1016\/j.brainres.2021.147444","article-title":"Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of Huntington disease","volume":"1762","author":"Moghaddam","year":"2021","journal-title":"Brain Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.31887\/DCNS.2016.18.1\/pnopoulos","article-title":"Huntington disease: A single-gene degenerative disorder of the striatum","volume":"18","author":"Nopoulos","year":"2022","journal-title":"Dialogues Clin. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","article-title":"The role of microglia and astrocytes in Huntington\u2019s disease","volume":"12","author":"Palpagama","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: A clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B66","first-page":"1817","article-title":"Huntington disease","volume-title":"Neuropsychopharmacology \u2013 5th generation of progress","author":"Ross","year":"2022"},{"key":"B67","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.ejhg.5200793","article-title":"Succinate dehydrogenase and human diseases: New insights into a well-known enzyme","volume":"10","author":"Rustin","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/1028415X.2020.1721645","article-title":"Piperine mitigates behavioral impairments and provides neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms","volume":"25","author":"Salman","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","article-title":"Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system","volume":"57","author":"Sandhir","year":"2010","journal-title":"Neurochem. Int."},{"key":"B70","doi-asserted-by":"publisher","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.9734\/bjast\/2014\/12745","article-title":"Synthesis and evaluation of analgesic and anti-inflammatory activities of most active free radical scavenging derivatives of mangiferin","volume":"4","author":"Sekar","year":"2014","journal-title":"Br. J. Appl. Sci. Technol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"307","DOI":"10.9734\/arrb\/2015\/12669","article-title":"Molecules of interest\u2013Mangiferin\u2013A review","volume":"5","author":"Sekar","year":"2015","journal-title":"Annu. Res. Rev. Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/22311866.2014.921121","article-title":"Investigation of mangiferin, as a promising natural polyphenol xanthone on multiple targets of Alzheimer's disease","volume":"4","author":"Sethiya","year":"2014","journal-title":"J. Biol. Act. Prod. Nat."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00210-021-02106-1","article-title":"Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington\u2019s disease","volume":"394","author":"Sharma","year":"2021","journal-title":"Naunyn-Schmiedeberg's Archives Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5214\/ans.0972.7531.220104","article-title":"Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid","volume":"22","author":"Shetty","year":"2015","journal-title":"Ann. Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3109\/01480545.2013.776583","article-title":"Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats","volume":"36","author":"Shivasharan","year":"2013","journal-title":"Drug Chem. Toxicol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s11064-015-1658-2","article-title":"Piperine enhances the protective effect of curcumin against 3-NP induced neurotoxicity: Possible neurotransmitters modulation mechanism","volume":"40","author":"Singh","year":"2015","journal-title":"Neurochem. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11011-016-9929-4","article-title":"Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington\u2019s disease model in rats","volume":"32","author":"Suganya","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"B81","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/00207454.2013.872642","article-title":"Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum","volume":"124","author":"Thangarajan","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: Past, present and future","volume":"15","author":"Tunez","year":"2010","journal-title":"Molecules"},{"key":"B83","doi-asserted-by":"publisher","first-page":"577380","DOI":"10.1016\/j.jneuroim.2020.577380","article-title":"Inflammation in huntington's disease: A few new twists on an old tale","volume":"348","author":"Valadao","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13023-021-01699-3","article-title":"Validation of diagnostic codes and epidemiologic trends of huntington disease: A population-based study in navarre, Spain","volume":"16","author":"Vicente","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"104939","DOI":"10.1016\/j.neuint.2020.104939","article-title":"Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders","volume":"143","author":"Walia","year":"2020","journal-title":"Neurochem. Int."},{"key":"B95","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-5-18","article-title":"Tetrabenazine is neuroprotective in Huntington\u2019s disease mice","volume":"5","author":"Wang","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"B86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biopha.2016.11.111","article-title":"Effect of Praeruptorin C on 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in mice","volume":"86","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"11883","DOI":"10.1038\/s41598-017-12160-6","article-title":"Nrf2\/HO-1 mediates the neuroprotective effect of mangiferin on early brain injury after subarachnoid hemorrhage by attenuating mitochondria-related apoptosis and neuroinflammation","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1212\/01.wnl.0000052992.58107.67","article-title":"Predictors of nursing home placement in Huntington disease","volume":"60","author":"Wheelock","year":"2003","journal-title":"Neurology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nutres.2020.12.017","article-title":"Oral administration of mangiferin ameliorates diabetes in animal models: A meta-analysis and systematic review","volume":"87","author":"Wu","year":"2021","journal-title":"Nutr. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"9.52.1","DOI":"10.1002\/cpns.10","article-title":"The revised neurobehavioral severity scale (NSS-R) for rodents","volume":"75","author":"Yarnell","year":"2016","journal-title":"Curr. Protoc. Neurosci."},{"key":"B91","first-page":"88","article-title":"Therapeutic potentials of superoxide dismutase","volume":"12","author":"Younus","year":"2018","journal-title":"Int. J. Health Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3892\/ol.2012.931","article-title":"Redox status expressed as GSH: GSSG ratio as a marker for oxidative stress in paediatric tumour patients","volume":"4","author":"Zitka","year":"2012","journal-title":"Oncol. Lett."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1189957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T10:27:38Z","timestamp":1689244058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1189957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":95,"alternative-id":["10.3389\/fphar.2023.1189957"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1189957","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"article-number":"1189957"}}